Other Preterm Infants Clinical Trial
— NICU-MTOfficial title:
Cognitive Processing in Preterm Infants and NICU Music Therapy
Verified date | March 2020 |
Source | Saskatchewan Health Authority - Regina Area |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Several positive physiological and behavioural outcomes have been observed in preterm infants
exposed to music therapy during their stay at Neonatal Intensive Care Units (NICU). There is
ample evidence in the literature showing that brief exposure to music can lead to superior
performance on a host of cognitive tasks in laboratory settings in children, adolescent and
adults. However, till date no study has examined the cognitive benefits of NICU music therapy
in preterm infants. Further habituation tests have been employed to examine cognitive
functioning in infants in laboratory setting but the same test have not been employed as a
measure to examine early cognitive functioning in preterm infants.
This project will be carried out to examine the benefits of NICU music therapy on the
cognitive functioning of preterm infants born at 27- 33 weeks of gestational age. A
randomized controlled research design will be employed to compare cognitive functioning
between the treatment and control group at 18 - 24 months of corrected gestational age. The
treatment group will be exposed to music therapy during their stay in NICU and the controlled
group will be exposed to all standardized care available at our institution except music
therapy. Habituation tests will be used to examine cognitive functioning of the preterm
infants in groups at 18 - 24 months of gestational age.
Status | Active, not recruiting |
Enrollment | 102 |
Est. completion date | December 2020 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 27 Weeks to 33 Weeks |
Eligibility |
Inclusion Criteria: 1. Gestation age 27-33 weeks (maternal dates or early fetal ultrasound) 2. Is not on ventilators 3. Written informed consent forms has been signed from the infant's legal guardian Exclusion Criteria: 1. Infants with congenital abnormalities 2. Severe intraventricular hemorrhage, with ventriculomegaly or parenchymal hemorrhage 3. Infants with known or suspected prenatal exposure to substance 4. Infants receiving palliative care at NICU 5. Infants who are on ventilators 6. Infants whose legal guardian did not sign the consent forms |
Country | Name | City | State |
---|---|---|---|
Canada | Regina General Hospital, Neonatal Intensive Care Unit, Deaprtment of Pediatrics | Regina | Saskatchewan |
Lead Sponsor | Collaborator |
---|---|
Saskatchewan Health Authority - Regina Area | University of Regina |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Other outcomes | Average difference in weight gain (total calorie intake) between experimental and control group | Baseline to 3 weeks when music therapy is complete | |
Other | Other outcome | Average difference in length of hospitalization between experimental group and control group | Baseline | |
Other | Other outcome | Average difference in neurological assessment score between experimental group and control group | Baseline | |
Other | Other outcome | Average difference in hearing assessment between experimental group and control group | Baseline | |
Primary | Time looking at a familiar stimulus | Average difference in rate of habituation as measure by the time looking at a familiar stimulus in mili-seconds between experimental and control groups. | 18 - 24 months | |
Secondary | Physiological measure | Average difference in heart rate before music therapy to after music therapy from before to during and from during to after music therapy. | 15 minutes,before, during, after music therapy, 6 days a week | |
Secondary | Physiological measure | Average difference in breathing rate before music therapy to after music therapy from before to during and from during to after music therapy. | 15 minutes,before, during, after music therapy, 6 days a week | |
Secondary | Physiological measure | Average difference in oxygen saturation before music therapy to after music therapy from before to during and from during to after music therapy. | 15 minutes,before, during, after music therapy, 6 days a week | |
Secondary | Behavioral measure | Difference in sleep between experimental and control group | Before to after music therapy 6 days a week | |
Secondary | Behavioral measure | Difference in apnea between experimental and control group | Before to after music therapy 6 days a week | |
Secondary | Behavioral measure | Difference in Bradycardia (number and severity) between experimental and control group | Before to after music therapy 6 days a week | |
Secondary | Behavioral measure | Difference in de-saturation degree of it between experimental and control group | Before to after music therapy 6 days a week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02231801 -
Monitoring of Vital Signs During Skin-to-skin Holding by Mothers of Their Preterm Babies
|
N/A | |
Completed |
NCT01450436 -
Impact of Preterm Body Composition at Discharge on 2 Years Neurological Development (ASQ Evaluation)
|
||
Completed |
NCT02268968 -
Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure
|
Phase 1 | |
Completed |
NCT02073071 -
Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants
|
N/A | |
Withdrawn |
NCT02224859 -
Invictus Medical, Medical Cranial Support Device (CSD) is a Device Safety Study in Infants at Risk of Head Ulcers.
|
N/A | |
Completed |
NCT01944956 -
Swallowing Sound in Preterm Infant Evaluation of Feeding Maturation
|
N/A | |
Terminated |
NCT02040909 -
Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation
|
Phase 1 | |
Not yet recruiting |
NCT01772927 -
Clinical Tolerance of Numeta 13%
|
N/A | |
Completed |
NCT00233324 -
Surfactant Positive Airway Pressure and Pulse Oximetry Trial
|
Phase 3 | |
Completed |
NCT02192996 -
Probiotic Supplementation to Improve the GUT Microbiota of Very Low Birth Weight Preterm, a Pilot Study
|
Phase 0 | |
Completed |
NCT02404623 -
The Effect of Vitamin D Administration to Premature Infants on Vitamin D Status and Respiratory Morbidity
|
N/A |